580 articoli
New research reveals how RA affects muscle biomechanics within 6 months of symptom onset, offering insights for early intervention.
Large Hong Kong registry study tracked how well patients stayed on newer JAK inhibitors versus traditional TNF blockers for RA treatment.
Small trial tests innovative immune cell therapy for patients with relapsed non-Hodgkin's lymphoma who failed standard treatments.
Genetically modified immune cells target blood cancer that stopped responding to standard treatments in 28-patient trial.
Researchers modified children's own immune cells to fight B-cell leukemia and lymphoma when standard treatments failed.
Phase II trial tests checkpoint inhibitors given before surgery to shrink tumors and improve outcomes in stage III-IV melanoma patients.
New viral therapy ASP9801 targets solid tumors directly, potentially offering hope for patients with advanced metastatic cancer.
University of Arizona researchers tested psychedelic therapy for OCD symptoms in 15-person clinical trial over four years.
University of Zurich researchers tested psilocybin against placebo in 37 alcohol-dependent patients using rigorous double-blind methodology.
60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.
University researchers used psychedelic therapy and brain imaging to tackle cocaine addiction, revealing new neural pathways for recovery.
Large 6-year study tested dietary interventions including caloric restriction and omega-3s in 330 people with mild cognitive impairment.
